EveryDose, a leading provider of medication management and patient engagement solutions, today announced the successful completion of its SOC 2 Type II and HIPAA certification for the third consecutive year. This achievement underscores EveryDose’s ongoing commitment to upholding the highest standards of data security, privacy, and compliance in the healthcare industry.
The SOC 2 Type II certification, issued by an independent third-party auditor, validates that EveryDose’s internal controls meet stringent security, availability, and confidentiality requirements. In addition, the company maintains compliance with the Health Insurance Portability and Accountability Act (HIPAA), ensuring that patient health data is handled with the highest level of protection.
“Maintaining SOC 2 Type II and HIPAA certification for three consecutive years reflects our unwavering commitment to security and compliance,” said Andrew Hourani, Founder & CEO of EveryDose. “As we continue to expand our partnerships with health systems, health plans, and pharmaceutical organizations, safeguarding patient data remains our top priority. This milestone reinforces our dedication to providing a secure, trusted platform for medication management and patient engagement.”
EveryDose’s compliance with SOC 2 Type II and HIPAA provides reassurance to healthcare organizations that their data is protected through rigorous security protocols, continuous monitoring, and proactive risk management. This certification reflects the company’s broader mission to empower care teams and patients with innovative, data-driven medication solutions—without compromising security.
For more information about EveryDose’s security practices and solutions, visit www.everydose.ai or email info@everydose.ai.